SWTX (SpringWorks Therapeutics, Inc. Common Stock) Stock Analysis - Insider Trades
SpringWorks Therapeutics, Inc. Common Stock (SWTX) is a publicly traded Healthcare sector company. As of May 20, 2026, SWTX trades at $46.99 with a market cap of $3.48B and a P/E ratio of -13.78. SWTX moved +0.00% today. Year to date, SWTX is +29.45%; over the trailing twelve months it is +25.21%. Its 52-week range spans $28.21 to $62.00. Analyst consensus is buy with an average price target of $47.00. Rallies surfaces SWTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading SWTX stock inside the company?
Recent SWTX insider activity includes Edris Badreddin sold 169.71K, LYNCH DANIEL sold 93.00K, Lewis-Hall Freda C sold 24.73K, Hambleton Julie sold 14.15K, and Fuhrman Alan sold 24.73K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Recent SWTX insider activity includes Edris Badreddin sold 169.71K, LYNCH DANIEL sold 93.00K, Lewis-Hall Freda C sold 24.73K, Hambleton Julie sold 14.15K, and Fuhrman Alan sold 24.73K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for SWTX?
Yes. Rallies tracks SWTX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is SWTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SWTX. It does not provide personalized investment advice.
